Brief Title
Evaluation of the Endovascular Repair for Aortic Aneurysm (EVAR) Program at LHSC
Official Title
Evaluation of the Endovascular Repair for Aortic Aneurysm (EVAR) Program at LHSC
Brief Summary
The purpose of this study is to compare the cost effectiveness, quality of life and outcomes of the endovascular stent graft repair with the open surgical repair of abdominal aortic aneurysms.
Detailed Description
Abdominal Aortic Aneurysms have been traditionally repaired using the standard open surgical technique. The use of Endovascular stent grafts(EVAR) to treat aortic aneurysms has been ongoing for approximately 8-10 years. Use of EVAR to treat aortic aneurysms in high risk has been reported to be beneficial. However, the costs of this therapy are quite significant and therefore in order to best understand the cost effectiveness of this type of aneurysm treatment, an extensive prospective comparative evaluation is required. This study will compare outcomes and cost-effectiveness for patients receiving EVAR, with high surgical risk, and OSR, with low surgical risk, and OSR, where there is high surgical risk and not suitable for EVAR based on anatomical complexity. Demographic, medical, health care resource utilization, cost, and quality of life information is collected from participating patients over a period of a year following repair.
Study Type
Interventional
Condition
Abdominal Aortic Aneurysm
Intervention
Endovascular vs Open Repair
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Procedure
Estimated Enrollment
130
Start Date
August 2003
Completion Date
August 2007
Primary Completion Date
June 2006
Eligibility Criteria
Inclusion Criteria: - infrarenal abdominal aortic aneurysm, - > 5.5 cm diameter - scheduled for elective surgical repair Exclusion Criteria: - previous repair of AAA
Gender
All
Ages
40 Years - N/A
Accepts Healthy Volunteers
No
Contacts
Gaetano DeRose, MD, FACS, FRCSC, ,
Administrative Informations
NCT ID
NCT00226629
Organization ID
R-03-155
Responsible Party
Sponsor
Study Sponsor
Lawson Health Research Institute
Study Sponsor
Gaetano DeRose, MD, FACS, FRCSC, Principal Investigator, LHSC, UWO
Verification Date
August 2017